Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma

Cheng-Lung Hsu, Hsin-Pai Li, Lang-Ming Chi et al.|Journal of Experimental & Clinical Cancer Research|2018

Cited by 36